Rapid assessment of drug response in cancer cells using microwell array and molecular imaging

Min S. Wang, Zhen Luo, Nitin Nitin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Selection of personalized chemotherapy regimen for individual patients has significant potential to improve chemotherapy efficacy and to reduce the deleterious effects of ineffective chemotherapy drugs. In this study, a rapid and high-throughput in vitro drug response assay was developed using a combination of microwell array and molecular imaging. The microwell array provided high-throughput analysis of drug response, which was quantified based on the reduction in intracellular uptake (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4- yl)amino]-2-deoxy-d-glucose) (2-NBDG). Using this synergistic approach, the drug response measurement was completed within 4 h, and only a couple thousand cells were needed for quantification. The broader application of this microwell molecular imaging approach was demonstrated by evaluating the drug response of two cancer cell lines, cervical (HeLa) and bladder (5637) cancer cells, to two distinct classes of chemotherapy drugs (cisplatin and paclitaxel). This approach did not require an extended cell culturing period, and the quantification of cellular drug response was 4-16 times faster compared with other cell-microarray drug response studies. Moreover, this molecular imaging approach had comparable sensitivity to traditional cell viability assays, i.e., the MTT assay and propidium iodide labeling of cellular nuclei;and similar throughput results as flow cytometry using only 1,000-2,000 cells. Given the simplicity and robustness of this microwell molecular imaging approach, it is anticipated that the assay can be adapted to quantify drug responses in a wide range of cancer cells and drugs and translated to clinical settings for a rapid in vitro drug response using clinically isolated samples. [Figure not available: see fulltext.]

Original languageEnglish (US)
Pages (from-to)4195-4206
Number of pages12
JournalAnalytical and Bioanalytical Chemistry
Volume406
Issue number17
DOIs
StatePublished - 2014

Fingerprint

Molecular imaging
Molecular Imaging
Cells
Pharmaceutical Preparations
Chemotherapy
Neoplasms
Assays
Drug Therapy
Throughput
Flow cytometry
Propidium
Microarrays
Paclitaxel
Urinary Bladder Neoplasms
Labeling
Cisplatin
Cell Survival
Flow Cytometry

Keywords

  • 2-NBDG
  • Cancer
  • Drug response
  • High throughput
  • Microwell array
  • Molecular imaging

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry

Cite this

Rapid assessment of drug response in cancer cells using microwell array and molecular imaging. / Wang, Min S.; Luo, Zhen; Nitin, Nitin.

In: Analytical and Bioanalytical Chemistry, Vol. 406, No. 17, 2014, p. 4195-4206.

Research output: Contribution to journalArticle

Wang, Min S. ; Luo, Zhen ; Nitin, Nitin. / Rapid assessment of drug response in cancer cells using microwell array and molecular imaging. In: Analytical and Bioanalytical Chemistry. 2014 ; Vol. 406, No. 17. pp. 4195-4206.
@article{e386ddcee35443fdae6420d461e71163,
title = "Rapid assessment of drug response in cancer cells using microwell array and molecular imaging",
abstract = "Selection of personalized chemotherapy regimen for individual patients has significant potential to improve chemotherapy efficacy and to reduce the deleterious effects of ineffective chemotherapy drugs. In this study, a rapid and high-throughput in vitro drug response assay was developed using a combination of microwell array and molecular imaging. The microwell array provided high-throughput analysis of drug response, which was quantified based on the reduction in intracellular uptake (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4- yl)amino]-2-deoxy-d-glucose) (2-NBDG). Using this synergistic approach, the drug response measurement was completed within 4 h, and only a couple thousand cells were needed for quantification. The broader application of this microwell molecular imaging approach was demonstrated by evaluating the drug response of two cancer cell lines, cervical (HeLa) and bladder (5637) cancer cells, to two distinct classes of chemotherapy drugs (cisplatin and paclitaxel). This approach did not require an extended cell culturing period, and the quantification of cellular drug response was 4-16 times faster compared with other cell-microarray drug response studies. Moreover, this molecular imaging approach had comparable sensitivity to traditional cell viability assays, i.e., the MTT assay and propidium iodide labeling of cellular nuclei;and similar throughput results as flow cytometry using only 1,000-2,000 cells. Given the simplicity and robustness of this microwell molecular imaging approach, it is anticipated that the assay can be adapted to quantify drug responses in a wide range of cancer cells and drugs and translated to clinical settings for a rapid in vitro drug response using clinically isolated samples. [Figure not available: see fulltext.]",
keywords = "2-NBDG, Cancer, Drug response, High throughput, Microwell array, Molecular imaging",
author = "Wang, {Min S.} and Zhen Luo and Nitin Nitin",
year = "2014",
doi = "10.1007/s00216-014-7759-y",
language = "English (US)",
volume = "406",
pages = "4195--4206",
journal = "Fresenius Zeitschrift fur Analytische Chemie",
issn = "0016-1152",
publisher = "Springer Verlag",
number = "17",

}

TY - JOUR

T1 - Rapid assessment of drug response in cancer cells using microwell array and molecular imaging

AU - Wang, Min S.

AU - Luo, Zhen

AU - Nitin, Nitin

PY - 2014

Y1 - 2014

N2 - Selection of personalized chemotherapy regimen for individual patients has significant potential to improve chemotherapy efficacy and to reduce the deleterious effects of ineffective chemotherapy drugs. In this study, a rapid and high-throughput in vitro drug response assay was developed using a combination of microwell array and molecular imaging. The microwell array provided high-throughput analysis of drug response, which was quantified based on the reduction in intracellular uptake (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4- yl)amino]-2-deoxy-d-glucose) (2-NBDG). Using this synergistic approach, the drug response measurement was completed within 4 h, and only a couple thousand cells were needed for quantification. The broader application of this microwell molecular imaging approach was demonstrated by evaluating the drug response of two cancer cell lines, cervical (HeLa) and bladder (5637) cancer cells, to two distinct classes of chemotherapy drugs (cisplatin and paclitaxel). This approach did not require an extended cell culturing period, and the quantification of cellular drug response was 4-16 times faster compared with other cell-microarray drug response studies. Moreover, this molecular imaging approach had comparable sensitivity to traditional cell viability assays, i.e., the MTT assay and propidium iodide labeling of cellular nuclei;and similar throughput results as flow cytometry using only 1,000-2,000 cells. Given the simplicity and robustness of this microwell molecular imaging approach, it is anticipated that the assay can be adapted to quantify drug responses in a wide range of cancer cells and drugs and translated to clinical settings for a rapid in vitro drug response using clinically isolated samples. [Figure not available: see fulltext.]

AB - Selection of personalized chemotherapy regimen for individual patients has significant potential to improve chemotherapy efficacy and to reduce the deleterious effects of ineffective chemotherapy drugs. In this study, a rapid and high-throughput in vitro drug response assay was developed using a combination of microwell array and molecular imaging. The microwell array provided high-throughput analysis of drug response, which was quantified based on the reduction in intracellular uptake (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4- yl)amino]-2-deoxy-d-glucose) (2-NBDG). Using this synergistic approach, the drug response measurement was completed within 4 h, and only a couple thousand cells were needed for quantification. The broader application of this microwell molecular imaging approach was demonstrated by evaluating the drug response of two cancer cell lines, cervical (HeLa) and bladder (5637) cancer cells, to two distinct classes of chemotherapy drugs (cisplatin and paclitaxel). This approach did not require an extended cell culturing period, and the quantification of cellular drug response was 4-16 times faster compared with other cell-microarray drug response studies. Moreover, this molecular imaging approach had comparable sensitivity to traditional cell viability assays, i.e., the MTT assay and propidium iodide labeling of cellular nuclei;and similar throughput results as flow cytometry using only 1,000-2,000 cells. Given the simplicity and robustness of this microwell molecular imaging approach, it is anticipated that the assay can be adapted to quantify drug responses in a wide range of cancer cells and drugs and translated to clinical settings for a rapid in vitro drug response using clinically isolated samples. [Figure not available: see fulltext.]

KW - 2-NBDG

KW - Cancer

KW - Drug response

KW - High throughput

KW - Microwell array

KW - Molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=84903783953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903783953&partnerID=8YFLogxK

U2 - 10.1007/s00216-014-7759-y

DO - 10.1007/s00216-014-7759-y

M3 - Article

C2 - 24760393

AN - SCOPUS:84903783953

VL - 406

SP - 4195

EP - 4206

JO - Fresenius Zeitschrift fur Analytische Chemie

JF - Fresenius Zeitschrift fur Analytische Chemie

SN - 0016-1152

IS - 17

ER -